Target intelligence / Profile preview

Fimbrial antigen type 3

Molecular classification
Bacterial adhesin, Surface protein complex, Other (Fimbria/pilus structure)
01

Overview

Fimbrial antigen type 3 is a bacterial surface protein complex classified as a fimbria or pilus, primarily found on the surface of many Gram-negative bacteria. These structures are composed of polymeric protein subunits—mainly pilin—and function as key adhesins that enable bacteria to bind specifically to glycoprotein or glycolipid receptors on host cell surfaces. This adhesion is critical for initial colonization, biofilm formation, and resistance to physical removal from tissues. The adhesive tip at the end of each fimbria determines receptor specificity and can vary between strains, contributing both to tissue tropism and immune evasion. Proteins associated with fimbriae act as antigens that stimulate adaptive immunity by being recognized by antibodies and lymphocyte receptors. While not an enzyme or classical receptor in human pharmacology terms, "Fimbrial antigen type 3" is considered a valid therapeutic target due to its essential role in infection establishment by pathogenic bacteria such as Escherichia coli[1][2][3].

Other names
Type 3 fimbrial antigenType 3 fimbriaFimbriae type 3Fim3
02

Mechanism of action

Inhibition would block bacterial adhesion to host cells.

03

Biological functions

Adhesion to host cells and surfacesInitiation of colonizationEvasion of host immune responseAntigenic determinant for adaptive immunity
04

Disease associations

Infection (especially in Gram-negative bacterial pathogens)Colonization and persistence in host tissues

Beyond the preview

Go deeper on Fimbrial antigen type 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fimbrial antigen type 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call